Medical devices, healthcare technology and the business of care
510(k) clearance · K261415

Injectable Root Canal Sealer (KP-Root SP)

Guilin Kevin Peter Technology Co., Ltd. · Decision date Jun 29, 2026

FDA DECISIONK261415

What did the FDA decide?

FDA records K261415 as a 510(k) premarket notification, with a decision dated Jun 29, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Jun 29, 2026

FDA source record

Regulatory record facts

Identifier
K261415
Regulatory pathway
510(k) premarket notification
Product code
KIF
Decision code
SESE
Decision date
Jun 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Resin, Root Canal Filling.

Product code
KIF
FDA device class
2

FDA decision timeline

  1. K261415 received

    Application receipt date recorded by FDA.

  2. K261415 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code KIF

Product / regulatory recordCompanyPathwayDecision dateSource
BCS Device Pte., Ltd.510(k) clearanceOct 16, 2026FDA
Vioseal XK262050
Spident Co., Ltd.510(k) clearanceSep 11, 2026FDA
NuSmile, Ltd.510(k) clearanceSep 4, 2026FDA
Guilin Kevin Peter Technology Co., Ltd.510(k) clearanceAug 25, 2026FDA
Any-PasteK253167
Mediclus Co., Ltd.510(k) clearanceJan 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Guilin Kevin Peter Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Guilin

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records